Cargando…
One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products
Montelukast is a weak acid drug characterized by its low solubility in the range of pH 1.2 to 4.5, which may lead to dissolution-limited absorption. The aim of this paper is to develop an in vivo predictive dissolution method for montelukast and to check its performance by establishing a level-A in...
Autores principales: | Prieto-Escolar, Mercedes, Torrado, Juan J., Álvarez, Covadonga, Ruiz-Picazo, Alejandro, Simón-Vázquez, Marta, Govantes, Carlos, Frias, Jesús, García-Arieta, Alfredo, Gonzalez-Alvarez, Isabel, Bermejo, Marival |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151440/ https://www.ncbi.nlm.nih.gov/pubmed/34064700 http://dx.doi.org/10.3390/pharmaceutics13050690 |
Ejemplares similares
-
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products
por: Gonzalez-Alvarez, Isabel, et al.
Publicado: (2021) -
Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
por: Figueroa-Campos, Andrés, et al.
Publicado: (2020) -
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
por: González-Álvarez, Isabel, et al.
Publicado: (2022) -
Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products
por: Ruiz-Picazo, Alejandro, et al.
Publicado: (2019) -
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
por: Bermejo, Marival, et al.
Publicado: (2020)